After completing his service, he returned to Alcoa. Seeing a void in the ... After 20 years of research, the first clinical treatment trial was completed last month. Bob is survived by his wife ...

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

Flatiron Health, a healthtech company transforming clinical research through technology that integrates research into everyday care, today announced a collaboration with NRG Oncology (NRG), a clinical ...

Alcoa CEO warns tariffs could cost 100,000 U.S. jobs Tariffs not enough to restart Alcoa's U.S. facilities, CEO says Alcoa seeks Canadian aluminum exemption, cites power cost concerns Trump ...

Piotr Swat / SOPA Images / LightRocket / Getty Images Alcoa CEO William Oplinger said Tuesday he believes President Donald Trump's proposed tariffs on aluminum and steel would result in fewer US ...

The business conducted clinical trials of new potential drug treatments on behalf of sponsor companies seeking approval from ...

Aluminum producer Alcoa said on Tuesday that US President Donald Trump’s plan to impose a tariff on aluminum imports could cost about 100,000 U.S. jobs and would itself not be enough to ...

Alcoa's CEO explains why proposed aluminum tariffs could have far-reaching consequences for American workers. STORY HIGHLIGHTS Alcoa CEO warns 25% aluminum tariff could eliminate 100,000 U.S. jobs ...

Our next trending ticker is Alcoa. The aluminum producer warning on Tuesday that President Trump's plan to impose a tariff on aluminum imports could cost about 100,000 US jobs and would itself not ...

Bill Oplinger, CEO of Pittsburgh-based aluminum producer Alcoa, warned Tuesday that President Donald Trump’s 25% import tax on aluminum could kill off around 100,000 U.S jobs. “This is bad for ...